Coronary Microvascular Dysfunction and Estrogen Receptor Signaling

Trends Endocrinol Metab. 2020 Mar;31(3):228-238. doi: 10.1016/j.tem.2019.11.001. Epub 2019 Nov 29.

Abstract

Chest pain with non-obstructive coronary artery disease (NOCAD) occurs more frequently in women than in men and is mainly related to coronary microvascular disease (CMD). The majority of CMD patients are postmenopausal women, suggesting a role for lack of estrogens in the development and progression of CMD. Patients are often discharged without a clear treatment plan due to the limited understanding of etiology and diagnostic parameters of CMD and have significantly higher rates of future cardiovascular events. Thus, there is a need for a better understanding of the underlying biology, and CMD-specific diagnostic tests and therapies. In this article, we reviewed recent studies on CMD, estrogen action in coronary microvasculature, and diagnosis and treatment options for CMD in postmenopausal women.

Keywords: HRT; coronary microvascular dysfunction; diagnostic test; estrogen receptor signaling; estrogens; menopause.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Coronary Artery Disease* / genetics
  • Coronary Artery Disease* / metabolism
  • Coronary Artery Disease* / physiopathology
  • Estrogens / deficiency
  • Estrogens / pharmacology
  • Female
  • Humans
  • Male
  • Microcirculation / drug effects
  • Microcirculation / genetics
  • Microcirculation / physiology
  • Postmenopause / physiology
  • Receptors, Estrogen / physiology*
  • Sex Characteristics
  • Signal Transduction / drug effects
  • Signal Transduction / genetics

Substances

  • Estrogens
  • Receptors, Estrogen